TipRanks on MSN
Cybin to Release Q2 Financial Results and Business Update
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals ...
Priority Technology Holdings, Inc. ("Priority" or the "Company"), the payments and banking solution that streamlines collecting, storing, lending, and sending money to unlock revenue opportunities, ...
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery ...
Cybin announced that its Chief Medical Officer, Amir Inamdar, will participate in a panel at the 2025 Milken Institute Future of Health Summit. This participation underscores Cybin’s commitment to ...
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage ...
Pfizer Inc. upped its original $7.3 billion September offer to buy Metsera Inc., but the obesity specialist maintained that a now-improved unsolicited bid by semaglutide developer Novo Nordisk A/S is ...
Cybin is a breakthrough Phase 3 clinical-stage neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the ...
Business Wire News Releases MiriCanvas Unveils AI-powered 'Match Your Vibe' Feature to Recommend Brand-Aligned Design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results